MedPath

Feasibility of allocating the freshest available red blood cells to critically ill patients: a pilot study

Not Applicable
Conditions
blood transfusion in critically ill
Blood - Anaemia
Public Health - Epidemiology
Registration Number
ACTRN12610000736044
Lead Sponsor
Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

Patients hospitalised in the intensive care unit
Age equal or higher than 18 years
Require administration of at least one red blood cells unit

Exclusion Criteria

Palliative care
Transplant
Oncology and Haematology patients
Patients with known red blood cells antibodies requiring antigen negative units (Patients will be withdrawn from the study if the requirement for antigen-specific red cells is identified after randomisation)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the primary aim of this study is to determine feasibility of allocating the freshest available red blood cells in critically ill patients.<br>We will calculate the percentage of patients randomized among the eligible patients. The good communication between the intensive care unit-team and the blood bank team. and we will calculate the percentage of red blood cell packs younger than 7 days in each study group.[At the end of the 6 week study period];the primary aim of this study is to determine feasibility of allocating the freshest available red blood cells in critically ill patients[At the end of the 6 week study period]
Secondary Outcome Measures
NameTimeMethod
The median age of all RBC units received by the freshest red blood cells (RBC) unit group will be compared to the median age of RBC units received by the standard care group[At the end of the 6 week study period];The median age of all RBC units received by the freshest red blood cells (RBC) unit group will be compared to the median age of RBC units received by the standard care group[At the end of the 6 week study period]
© Copyright 2025. All Rights Reserved by MedPath